News from September 2012

HIVACAT has been licensed by the CSIC to develop a vaccine against HIV

The HIVACAT program for the development of this vaccine today announced the obtention of a license to advance in the development of a possible vaccin1

Clínic Barcelona

September 19 2012

Thaís Armangué was the best rated candidate in the 2012 PFIS call

The Ayudas predoctorales de Formación en Investigación en Salud (PFIS) is one of the main funding resources of the Institute of Health Carlos III, Mi1

Clínic Barcelona

September 14 2012

B•Debate interviews Dr. María Victoria Sánchez-Vives: “In a few years we’ll be able to apply virtual reality to medical practice”

Dr. Sánchez-Vives was scientific co-director of the debate workshops How Mind Emerges from Brain: a View into the Future organized by B·Debate Intern1

Clínic Barcelona

September 5 2012

Scientists Discover that Vivax Malaria Has Shaped the Evolution of the Human Genome in the Asia-Pacific Region

It has long been assumed that P. falciparum, the species that causes the most severe disease and most deaths from malaria, is the most important driv1

News from September 2012

HIVACAT has been licensed by the CSIC to develop a vaccine against HIV

Thaís Armangué was the best rated candidate in the 2012 PFIS call

B•Debate interviews Dr. María Victoria Sánchez-Vives: “In a few years we’ll be able to apply virtual reality to medical practice”

Scientists Discover that Vivax Malaria Has Shaped the Evolution of the Human Genome in the Asia-Pacific Region

Subscribe to the Newsletter of Clínic